Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 299
interventional 215
Observational 77
Registry 7

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 105
Drug|placebo 36
Biological 16
Biological|placebo 7
Device 7
Other 6
Drug|Other 5
Procedure 5
Biological|Drug 4
Biological|Drug|placebo 2
Biological|Drug|Procedure|Radiation 2
Biological|Other 2
Device|Drug 2
Dietary Supplement 2
Drug|Other|Procedure|Radiation 2
Behavioral 1
Biological|Dietary Supplement|Drug|Procedure 1
Biological|Drug|Other 1
Biological|Drug|Procedure 1
Device|Other 1
Device|Procedure 1
Diagnostic Test 1
Dietary Supplement|placebo 1
Drug|Genetic|Other 1
Drug|Other|placebo 1
Drug|Procedure|Radiation 1
Other|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 72
China 38
NA 23
France 9
Italy 6
Netherlands 3
Canada 2
Egypt 2
Germany 2
India 2
Japan 2
Korea, Republic of 2
Norway 2
United Kingdom 2
Australia 1
Australia|Belgium|Bulgaria|Czechia|Netherlands|New Zealand|Poland|Singapore|Slovakia|South Africa|Ukraine 1
Australia|Bulgaria|Czechia|Georgia|Germany|Italy|Moldova, Republic of|Poland|Romania|Spain|United Kingdom 1
Australia|United Kingdom 1
Austria|Belgium|China|Germany|Hong Kong|Italy|Netherlands|Portugal|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
Austria|Belgium|Czechia|France|Germany|Hungary|Poland|Spain|Ukraine|United Kingdom 1
Belgium|China|France|Greece|Hong Kong|Ireland|Korea, Republic of|Netherlands|Peru|Poland|Romania|Tunisia 1
Bulgaria|Czechia|Germany|Hungary|Serbia|Spain 1
Canada|Netherlands 1
Canada|Netherlands|Norway 1
China|United States|Argentina|Australia|Belgium|Brazil|Canada|Czechia|France|Germany|Israel|Italy|Japan|Mexico|Romania|Russian Federation|Spain 1
France|Germany 1
France|Germany|Italy|Slovenia 1
Georgia|Moldova, Republic of|Poland 1
Hong Kong 1
Iran, Islamic Republic of 1
Poland|Portugal|Korea, Republic of|United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|France|Germany|Hungary|Italy|Spain|Taiwan|Thailand|United Kingdom 1
Russian Federation 1
Singapore 1
Spain 1
Sweden 1
Switzerland 1
Turkey|United States|Australia|Belgium|Brazil|Canada|Czechia|France|Hungary|Israel|Mexico|Poland|Russian Federation|South Africa|Spain|Switzerland|United Kingdom 1
Ukraine 1
Ukraine|Spain|United States|Belgium|France|Hungary|Italy|Japan|Netherlands|Poland|Russian Federation 1
United States|Argentina|Austria|Brazil|Bulgaria|Canada|Colombia|Greece|Hungary|Italy|Mexico|Peru|Poland|Romania|Russian Federation|Spain|Turkey|Ukraine 1
United States|Argentina|Austria|Bulgaria|Czech Republic|Germany|Hungary|India|Italy|Korea, Republic of|Mexico|Peru|Poland|Romania|Russian Federation|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Argentina|Belgium|Brazil|Canada|Czechia|Germany|Greece|Hong Kong|Hungary|Ireland|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Puerto Rico|Russian Federation|Spain|Taiwan|Thailand 1
United States|Argentina|Brazil|Bulgaria|Chile|Colombia|Greece|Hungary|Mexico|Peru|Poland|Romania|Russian Federation|Spain|Turkey|Ukraine 1
United States|Argentina|Czech Republic|Germany|Hong Kong|Israel|Italy|Poland|Russian Federation|Spain|Taiwan|Thailand|United Kingdom 1
United States|Argentina|Mexico 1
United States|Australia|Belgium|Brazil|Canada|Czechia|Denmark|Finland|France|Germany|Greece|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Norway|Poland|Portugal|Spain|Sweden|Turkey|United Kingdom 1
United States|Australia|Canada 1
United States|Australia|Canada|Spain 1
United States|Australia|Czechia|France|Germany|Italy|Poland|Spain|United Kingdom 1
United States|Australia|France|Greece|Hong Kong|Poland|Russian Federation|Singapore 1
United States|Austria|Canada|Germany|Hungary|Ireland|Italy|Portugal 1
United States|Belgium|Canada|Czech Republic|Finland|Germany|Greece|Hungary|India|Ireland|Israel|Italy|Poland 1
United States|Bosnia and Herzegovina|Canada|Croatia|Czechia|France|Germany|Hungary|Italy|Poland|Russian Federation|Serbia 1
United States|Brazil|Denmark|France|Germany|Hong Kong|Italy|Korea, Republic of|Puerto Rico|Taiwan|United Kingdom 1
United States|Canada 1
United States|Canada|France|Netherlands|Spain|United Kingdom 1
United States|China|Hungary|Poland|Russian Federation|Serbia|Ukraine 1
United States|France|Germany|Puerto Rico|United Kingdom 1
United States|Germany|United Kingdom 1
United States|Greece|Korea, Republic of|Poland|Spain 1
United States|Italy|Poland|Russian Federation 1
United States|Norway 1

Sites per Study

Site_count Study_Count
1 132
2 8
3 7
4 3
5 5
6 3
7 2
8 2
9 2
10 4
11 1
12 1
13 2
14 3
16 1
19 1
20 2
21 2
22 1
23 1
25 2
26 1
28 2
29 1
30 2
31 1
33 2
38 2
48 1
51 1
52 1
58 1
59 1
63 1
65 1
71 2
73 1
78 1
83 1
86 1
95 1
110 1
113 1
120 1
122 1
196 1

Phase

Phase Study_Count
Phase 2 70
Phase 3 54
Phase 1 26
Phase 4 23
N/A 22
Phase 1/Phase 2 13
Phase 2/Phase 3 5
Early Phase 1 2

Number of Arms

Number_of_Arms Count_of_Studies
1 80
2 73
3 19
4 12
5 5
7 1
8 1
10 1
NA 23

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 3.00 4.0000 9.00 16.00000 4.00000 39.0 8.0000 10.0000
1st Qu. 31.75 20.0000 21.00 24.75000 25.00000 75.0 67.0000 27.0000
Median 60.50 60.0000 29.00 33.50000 43.00000 102.0 116.0000 58.0000
Mean 60.50 211.7619 55.48 31.08333 61.21739 127.2 170.8519 117.7391
3rd Qu. 89.25 180.0000 48.00 38.25000 72.00000 200.0 203.7500 135.0000
Max. 118.00 960.0000 536.00 40.00000 250.00000 220.0 1351.0000 842.0000

Trial Group Type

group_type Group_Count
Experimental 238
Active Comparator 73
Placebo Comparator 54
NA 23
No Intervention 10
Other 5
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 106
Single Group Assignment 92
NA 10
Crossover Assignment 5
Sequential Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 178
Supportive Care 18
Prevention 10
Other 4
Diagnostic 3
Basic Science 1
Health Services Research 1

Observational Studies

Studies by Country

Country Study_Count
United States 25
NA 15
France 11
China 5
Italy 4
Netherlands 4
Germany 2
United Kingdom 2
Canada 1
Greece 1
Malaysia 1
Mexico 1
Norway 1
Russian Federation 1
Spain 1
United States|Canada 1
United States|Sweden 1

Sites per Study

Site_count Study_Count
1 59
2 4
3 2
4 1
5 1
6 2
12 1
13 1
14 1
20 1
21 1
24 1
27 1
29 1

Enrollment Metrics

Measure Observational
Min 1.0000
1st Qu 40.0000
Median 100.0000
Mean 762.8182
3rd Qu 285.0000
Max 23470.0000

Observation Model

observational_model Study_Count
Cohort 43
Case-Only 10
NA 8
Case-Control 6
Other 6
Case Control 3
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 44
Retrospective 23
Cross-Sectional 5
NA 4
Other 1

Registries

Studies by Country

Country Study_Count
United States 2
Australia|Colombia|Korea, Republic of|Kuwait|Malaysia|Singapore|Taiwan|Thailand|Turkey|Uruguay 1
Austria 1
France 1
NA 1
United States|Israel|Italy|Netherlands 1

Sites per Study

Site_count Study_Count
1 5
18 1
44 1

Enrollment Metrics

Measure Registries
Min 50.000
1st Qu 175.000
Median 500.000
Mean 4916.571
3rd Qu 1258.000
Max 31000.000

Registry Model

observational_model Study_Count
Cohort 7

Time Perspective

time_perspective Study_Count
Prospective 7

Follow-up

target_duration Study_Count
10 Years 2
1 Year 1
12 Months 1
24 Months 1
4 Years 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03394755 Thrombosomes® in Bleeding Thrombocytopenic Patients https://ClinicalTrials.gov/show/NCT03394755 Active, not recruiting Cellphire, Inc. 2019-08-03
NCT03362177 Study of Romiplostim for Chemo-induced Thrombocytopenia in Adults Subjects With Gastrointestinal or Colorectal Cancer https://ClinicalTrials.gov/show/NCT03362177 Recruiting Amgen 2022-01-17
NCT03355742 XIENCE 28 Global Study https://ClinicalTrials.gov/show/NCT03355742 Completed Abbott Medical Devices 2019-10-24
NCT03333486 Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer https://ClinicalTrials.gov/show/NCT03333486 Recruiting Roswell Park Cancer Institute 2022-09-06
NCT03304288 The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT03304288 Recruiting Peking University People’s Hospital 2020-08-31
NCT03275454 A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT03275454 Recruiting Sanofi 2022-05-31
NCT03258866 The Study of Different Dose Rituximab in the Treatment of ITP https://ClinicalTrials.gov/show/NCT03258866 Completed Shandong University 2015-12-31
NCT03229746 Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT03229746 Completed Assiut University 2018-06-01
NCT03201848 The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT03201848 Recruiting Qidong Gaitianli Medicines Co., Ltd 2021-12-31
NCT03177629 H. Pylori Eradication for Moderate ITP https://ClinicalTrials.gov/show/NCT03177629 Recruiting Seoul National University Hospital 2020-06-30
NCT03172676 Effects of Helicobacter Pylori Eradication in Children With Chronic Immune Thrombocytopenic Purpura https://ClinicalTrials.gov/show/NCT03172676 Recruiting Assiut University 2020-06-01
NCT03156452 Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & Mycophenolate https://ClinicalTrials.gov/show/NCT03156452 Active, not recruiting University Hospitals Bristol NHS Foundation Trust 2020-02-13
NCT03154385 Efficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT03154385 Completed Assistance Publique - Hôpitaux de Paris 2019-11-13
NCT03148912 Optimizing the Diagnosis of Heparin Induced Thrombocytopenia https://ClinicalTrials.gov/show/NCT03148912 Recruiting Ottawa Hospital Research Institute 2020-06-30
NCT03147638 Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT) https://ClinicalTrials.gov/show/NCT03147638 Recruiting Marshall University 2019-01-11
NCT03136445 TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia https://ClinicalTrials.gov/show/NCT03136445 Recruiting NHS Blood and Transplant 2020-12-30
NCT03102593 A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP https://ClinicalTrials.gov/show/NCT03102593 Completed argenx BVBA 2019-04-09
NCT03059030 Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia https://ClinicalTrials.gov/show/NCT03059030 Recruiting Northwestern University 2020-04-01
NCT03010202 The PROLONG Trial - Rituximab Maintenance Therapy in ITP https://ClinicalTrials.gov/show/NCT03010202 Recruiting Ostfold Hospital Trust 2023-12-31
NCT02964325 Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia https://ClinicalTrials.gov/show/NCT02964325 Recruiting Terumo BCTbio 2021-11-30
NCT02948283 Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT02948283 Active, not recruiting City of Hope Medical Center 2020-10-31
NCT02912208 Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT02912208 Recruiting Associazione Qol-one 2019-08-31
NCT02868099 Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT02868099 Completed Kyowa Hakko Kirin China Pharmaceutical Co., LTD. 2017-02-28
NCT02868060 Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT02868060 Completed Kyowa Hakko Kirin China Pharmaceutical Co., LTD. 2017-08-31
NCT02859909 This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT02859909 Completed Biotest 2018-12-31
NCT02845609 Efficacy of Sialic Acid GNE Related Thrombocytopenia https://ClinicalTrials.gov/show/NCT02845609 Completed Hadassah Medical Organization 2017-09-30
NCT02783313 Pathogen Reduction Evaluation & Predictive Analytical Rating Score https://ClinicalTrials.gov/show/NCT02783313 Completed Sanquin Research & Blood Bank Divisions 2016-04-30
NCT02718716 Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT02718716 Completed UCB Pharma 2019-02-28
NCT02707497 The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia https://ClinicalTrials.gov/show/NCT02707497 Recruiting Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 2021-10-31
NCT02679443 Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy https://ClinicalTrials.gov/show/NCT02679443 Completed Postgraduate Institute of Medical Education and Research 2016-12-31
NCT03090919 The INFUSE Trial - Intervening With Platelet Transfusions in Sepsis https://ClinicalTrials.gov/show/NCT03090919 Recruiting University of Kentucky 2020-12-31
NCT02578901 American Trial Using Tranexamic Acid in Thrombocytopenia https://ClinicalTrials.gov/show/NCT02578901 Active, not recruiting University of Washington 2020-06-30
NCT02556814 Caffeic Acid Combining High-dose Dexamethasone in Management of ITP https://ClinicalTrials.gov/show/NCT02556814 Completed Shandong University 2018-03-31
NCT02530515 Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT02530515 Completed M.D. Anderson Cancer Center 2018-04-30
NCT02501434 Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin https://ClinicalTrials.gov/show/NCT02501434 Recruiting University of Louisville 2019-03-31
NCT02487563 Prospective Study of Patients With Thrombocytopenia Following HSCT https://ClinicalTrials.gov/show/NCT02487563 Completed The First Affiliated Hospital of Soochow University 2019-04-12
NCT02422394 Eltrombopag for Inherited Thrombocytopenias https://ClinicalTrials.gov/show/NCT02422394 Completed IRCCS Policlinico S. Matteo 2018-03-31
NCT02402998 Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia https://ClinicalTrials.gov/show/NCT02402998 Active, not recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2018-05-22
NCT02391272 A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy https://ClinicalTrials.gov/show/NCT02391272 Completed Shandong University 2015-11-30
NCT02389621 Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures https://ClinicalTrials.gov/show/NCT02389621 Completed Shionogi Inc. 2017-04-05
NCT04224688 A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT04224688 Recruiting UCB Pharma 2022-07-31
NCT02351622 Caffeic Acid Tablets as a Second-line Therapy for ITP https://ClinicalTrials.gov/show/NCT02351622 Completed Shandong University 2013-12-31
NCT02335268 VALIDATION OF A PREDICTIVE MODEL OF RESPONSE TO ROMIPLOSTIM IN PATIENTS WITH IPSS LOW OR INTERMEDIATE-1 RISK MDS AND THROMBOCYTOPENIA https://ClinicalTrials.gov/show/NCT02335268 Recruiting Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH 2020-06-30
NCT02334813 Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT02334813 Completed University Hospital, Essen 2015-01-31
NCT02323178 A Study of Eltrombopag in Patients With CMML and Thrombocytopenia https://ClinicalTrials.gov/show/NCT02323178 Active, not recruiting Groupe Francophone des Myelodysplasies 2018-12-31
NCT02314273 Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALL https://ClinicalTrials.gov/show/NCT02314273 Completed Shanghai Children’s Medical Center 2014-04-30
NCT02298933 Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia https://ClinicalTrials.gov/show/NCT02298933 Completed National Institutes of Health Clinical Center (CC) 2017-08-08
NCT02287649 Polymorphism and Auto-reactive B and T Cells Subsets in Adult’s Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT02287649 Completed Assistance Publique - Hôpitaux de Paris 2015-10-02
NCT02267993 Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients https://ClinicalTrials.gov/show/NCT02267993 Completed Institute of Hematology & Blood Diseases Hospital 2018-08-01
NCT02227693 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia https://ClinicalTrials.gov/show/NCT02227693 Completed Eisai Inc. 2015-04-01
NCT02153060 An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT02153060 Completed Shandong University 2015-01-31
NCT02139501 An Investigation of rhTPO With Different Frequencies in the Management of ITP https://ClinicalTrials.gov/show/NCT02139501 Completed Shandong University 2015-01-31
NCT02104440 Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro https://ClinicalTrials.gov/show/NCT02104440 Completed Red de Terapia Celular 2017-03-31
NCT02078284 Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets https://ClinicalTrials.gov/show/NCT02078284 Completed U.S. Army Medical Research and Development Command 2016-07-31
NCT02074436 PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid) https://ClinicalTrials.gov/show/NCT02074436 Recruiting Emory University 2021-05-31
NCT02063789 An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT02063789 Completed Green Cross Corporation 2016-04-30
NCT01289509 A Study to Evaluate the Relative Bioavailability and Intra-Subject Variability of Two Lots of E5501 40 mg Tablets Administered Twice as Single Oral Doses to Healthy Subjects https://ClinicalTrials.gov/show/NCT01289509 Completed Eisai Inc. 2011-03-31
NCT01286038 Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia https://ClinicalTrials.gov/show/NCT01286038 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2020-09-30
NCT02039076 A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects https://ClinicalTrials.gov/show/NCT02039076 Completed Eisai Inc. 2014-06-30
NCT04274452 A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT04274452 Recruiting argenx BVBA 2021-09-01
NCT01980030 Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell https://ClinicalTrials.gov/show/NCT01980030 Completed Assistance Publique - Hôpitaux de Paris 2015-12-31
NCT01976104 Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure https://ClinicalTrials.gov/show/NCT01976104 Completed Eisai Inc. 2017-01-30
NCT01974401 Effect of Supragingival Irrigators Containing Chlorhexidine on Oral Health in Blood Dyscrasia https://ClinicalTrials.gov/show/NCT01974401 Completed Mashhad University of Medical Sciences 2011-03-31
NCT01972529 Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure https://ClinicalTrials.gov/show/NCT01972529 Completed Eisai Inc. 2017-01-26
NCT01966367 CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT01966367 Active, not recruiting Columbia University 2022-01-31
NCT01965626 A Multicenter Randomized Open-label Study of Oseltamivir Combined With HD-DEX Versus HD-DEX in the Management of ITP https://ClinicalTrials.gov/show/NCT01965626 Completed Shandong University 2018-05-31
NCT01963260 Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001) https://ClinicalTrials.gov/show/NCT01963260 Completed Merck Sharp & Dohme Corp. 2015-04-26
NCT01957176 A Rollover Study to Provide Continued Treatment With Eltrombopag https://ClinicalTrials.gov/show/NCT01957176 Active, not recruiting Novartis 2024-01-01
NCT01929980 Bortezomib to Treat Significant Complication of HSCT https://ClinicalTrials.gov/show/NCT01929980 Completed Children’s Hospital Medical Center, Cincinnati 2014-05-31
NCT01880047 Safety and Efficacy of Eltrombopag at Escalated Doses https://ClinicalTrials.gov/show/NCT01880047 Completed Weill Medical College of Cornell University 2017-02-15
NCT01808521 A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura https://ClinicalTrials.gov/show/NCT01808521 Completed Bloodworks 2017-07-31
NCT01791101 Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia. https://ClinicalTrials.gov/show/NCT01791101 Recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2018-12-31
NCT01789762 Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process https://ClinicalTrials.gov/show/NCT01789762 Completed Etablissement Français du Sang 2016-01-31
NCT01727401 Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia https://ClinicalTrials.gov/show/NCT01727401 Active, not recruiting G. d’Annunzio University 2020-12-31
NCT01719692 Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT01719692 Completed Institute of Hematology & Blood Diseases Hospital 2015-10-31
NCT01667263 The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT01667263 Completed Peking University People’s Hospital 2016-07-01
NCT01657552 Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT01657552 Completed GlaxoSmithKline 2012-10-26
NCT01621204 A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients https://ClinicalTrials.gov/show/NCT01621204 Completed McMaster University 2019-06-30
NCT01610180 Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs) https://ClinicalTrials.gov/show/NCT01610180 Completed Fondazione Progetto Ematologia 2018-06-30
NCT01586455 Human Placental-Derived Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT01586455 Active, not recruiting New York Medical College 2019-06-30
NCT01568333 A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT01568333 Completed Shandong University 2017-10-31
NCT01566695 The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS) https://ClinicalTrials.gov/show/NCT01566695 Active, not recruiting Celgene 2019-01-25
NCT01529827 Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01529827 Completed Roswell Park Cancer Institute 2015-05-28
NCT01520909 Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body. https://ClinicalTrials.gov/show/NCT01520909 Completed GlaxoSmithKline 2014-01-31
NCT01506414 Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT01506414 Completed Shandong University 2013-08-31
NCT01488565 A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia https://ClinicalTrials.gov/show/NCT01488565 Completed Peter MacCallum Cancer Centre, Australia 2014-05-31
NCT01481220 Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS) https://ClinicalTrials.gov/show/NCT01481220 Completed Nordic MDS Group 2013-05-31
NCT01444417 Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients https://ClinicalTrials.gov/show/NCT01444417 Completed Amgen 2015-02-28
NCT01440374 A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01440374 Completed Novartis 2015-03-31
NCT01438840 Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02) https://ClinicalTrials.gov/show/NCT01438840 Completed Eisai Inc. 2013-11-30
NCT01428635 Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy https://ClinicalTrials.gov/show/NCT01428635 Active, not recruiting M.D. Anderson Cancer Center 2020-01-31
NCT01355289 Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501 https://ClinicalTrials.gov/show/NCT01355289 Completed Eisai Inc. 2014-02-28
NCT01327872 Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects https://ClinicalTrials.gov/show/NCT01327872 Completed Eisai Inc. 2011-04-30
NCT04420494 Umbilical Cord Blood Treatment for Refractory Immune Cytopenia https://ClinicalTrials.gov/show/NCT04420494 Recruiting Peking Union Medical College Hospital 2022-04-20
NCT04368598 The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP https://ClinicalTrials.gov/show/NCT04368598 Recruiting Peking University People’s Hospital 2020-12-31
NCT04226950 Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in the Treatment of Childhood Essential Thrombocythemia https://ClinicalTrials.gov/show/NCT04226950 Recruiting Institute of Hematology & Blood Diseases Hospital 2022-07-20
NCT04217148 The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT04217148 Recruiting Peking University People’s Hospital 2022-12-31
NCT04089267 Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT04089267 Completed Shenyang Sunshine Pharmaceutical Co., LTD. 2018-12-31
NCT04083014 Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia https://ClinicalTrials.gov/show/NCT04083014 Recruiting Peking Union Medical College Hospital 2022-08-20
NCT04056195 Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT04056195 Recruiting Oscotec Inc. 2021-02-28
NCT04039477 A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP https://ClinicalTrials.gov/show/NCT04039477 Recruiting Kezar Life Sciences, Inc. 2020-12-31
NCT04014166 Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT04014166 Recruiting Institute of Hematology & Blood Diseases Hospital 2021-12-31
NCT03976882 Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy. https://ClinicalTrials.gov/show/NCT03976882 Recruiting Jiangsu HengRui Medicine Co., Ltd. 2020-08-30
NCT03951623 The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients https://ClinicalTrials.gov/show/NCT03951623 Recruiting Hutchison Medipharma Limited 2021-12-31
NCT03939637 Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children https://ClinicalTrials.gov/show/NCT03939637 Recruiting Baylor College of Medicine 2022-05-01
NCT03937154 Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer https://ClinicalTrials.gov/show/NCT03937154 Recruiting Amgen 2022-03-28
NCT03866798 Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT03866798 Recruiting Octapharma 2022-03-31
NCT03830749 Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura https://ClinicalTrials.gov/show/NCT03830749 Recruiting Humanity & Health Medical Group Limited 2020-12-31
NCT03815175 XIENCE 28 USA Study https://ClinicalTrials.gov/show/NCT03815175 Active, not recruiting Abbott Medical Devices 2020-12-31
NCT03771378 Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT03771378 Recruiting Wuhan Union Hospital, China 2020-05-01
NCT03712618 The SOLID Platelet Study https://ClinicalTrials.gov/show/NCT03712618 Recruiting National Institutes of Health Clinical Center (CC) 2021-12-31
NCT03701217 Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML https://ClinicalTrials.gov/show/NCT03701217 Recruiting Nanfang Hospital of Southern Medical University 2019-09-30
NCT03692754 Atorvastatin in Management of Newly Diagnosed ITP https://ClinicalTrials.gov/show/NCT03692754 Recruiting Shandong University 2021-12-01
NCT03664518 to Evaluate the Efficacy and Safety of Eltrombopag for Thrombocytopenia With Chronic HBV Infection https://ClinicalTrials.gov/show/NCT03664518 Recruiting Institute of Hematology & Blood Diseases Hospital 2019-10-31
NCT03638817 Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia https://ClinicalTrials.gov/show/NCT03638817 Recruiting University Hospital, Toulouse 2022-08-31
NCT03633019 High-dose Use of rhTPO in CIT Patients https://ClinicalTrials.gov/show/NCT03633019 Recruiting First Affiliated Hospital Xi’an Jiaotong University 2019-11-30
NCT03603132 A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics https://ClinicalTrials.gov/show/NCT03603132 Completed Jiangsu HengRui Medicine Co., Ltd. 2018-08-17
NCT03567798 Thrombocytopenia Induced by Chemotherapy https://ClinicalTrials.gov/show/NCT03567798 Completed Socrates School Of Health 2017-11-20
NCT03561909 Kinetics of Blood Platelets Transfused to Healthy Subjects https://ClinicalTrials.gov/show/NCT03561909 Completed Prophylix Pharma AS 2018-12-10
NCT03515096 Eltrombopag vs. rhTPO to Increase Platelet Level After HSCT https://ClinicalTrials.gov/show/NCT03515096 Recruiting Shenzhen Second People’s Hospital 2020-12-01
NCT03513328 Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation https://ClinicalTrials.gov/show/NCT03513328 Recruiting University of Florida 2021-06-30
NCT03471078 Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers https://ClinicalTrials.gov/show/NCT03471078 Recruiting Dova Pharmaceuticals 2020-11-30
NCT03421184 Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus https://ClinicalTrials.gov/show/NCT03421184 Recruiting University Hospital, Bordeaux 2020-11-30
NCT01224496 Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological Disorders https://ClinicalTrials.gov/show/NCT01224496 Completed Singapore General Hospital 2011-08-31
NCT01165996 Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT01165996 Completed Case Comprehensive Cancer Center 2011-12-31
NCT01163110 Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During Chemotherapy https://ClinicalTrials.gov/show/NCT01163110 Completed Midwestern Regional Medical Center 2007-06-30
NCT01147809 Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag https://ClinicalTrials.gov/show/NCT01147809 Completed GlaxoSmithKline 2015-01-31
NCT01143038 Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim https://ClinicalTrials.gov/show/NCT01143038 Completed Amgen 2013-09-20
NCT01133860 Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease https://ClinicalTrials.gov/show/NCT01133860 Completed IRCCS Policlinico S. Matteo 2010-06-30
NCT01129024 An Open-label Safety Study of S-888711 https://ClinicalTrials.gov/show/NCT01129024 Completed Shionogi Inc. 2011-08-31
NCT01071954 A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura https://ClinicalTrials.gov/show/NCT01071954 Completed Amgen 2017-01-12
NCT01002755 Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma https://ClinicalTrials.gov/show/NCT01002755 Completed M.D. Anderson Cancer Center 2018-01-31
NCT01000051 Eltrombopag for Post Transplant Thrombocytopenia https://ClinicalTrials.gov/show/NCT01000051 Completed M.D. Anderson Cancer Center 2018-04-04
NCT00961064 A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS) https://ClinicalTrials.gov/show/NCT00961064 Active, not recruiting National Institutes of Health Clinical Center (CC) 2017-08-10
NCT00948792 Study of the Effect of Differing Platelet Transfusion Times in Neonates https://ClinicalTrials.gov/show/NCT00948792 Completed University of Oklahoma 2010-12-31
NCT00931762 Safety and Efficacy of Panobinostat in Patients With Primary Myelofibrosis https://ClinicalTrials.gov/show/NCT00931762 Completed Novartis 2011-08-31
NCT00922883 A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients https://ClinicalTrials.gov/show/NCT00922883 Active, not recruiting National Institutes of Health Clinical Center (CC) 2013-05-07
NCT00914927 Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures https://ClinicalTrials.gov/show/NCT00914927 Completed Eisai Inc. 2011-11-11
NCT00908037 Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP) https://ClinicalTrials.gov/show/NCT00908037 Completed GlaxoSmithKline 2014-02-01
NCT00907478 Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP) https://ClinicalTrials.gov/show/NCT00907478 Completed Amgen 2014-01-09
NCT00903929 Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation https://ClinicalTrials.gov/show/NCT00903929 Completed University of Rochester 2015-12-31
NCT00903422 Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS) https://ClinicalTrials.gov/show/NCT00903422 Completed GlaxoSmithKline 2012-06-26
NCT00902018 Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP) https://ClinicalTrials.gov/show/NCT00902018 Completed Weill Medical College of Cornell University 2015-09-07
NCT00861692 Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II https://ClinicalTrials.gov/show/NCT00861692 Completed Mitsubishi Tanabe Pharma Corporation 2011-02-28
NCT04200456 A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT04200456 Recruiting UCB Pharma 2021-12-31
NCT04437953 Avatrombopag for Thrombocytopenia in People With Cancer https://ClinicalTrials.gov/show/NCT04437953 Recruiting Memorial Sloan Kettering Cancer Center 2022-05-31
NCT01349790 Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT01349790 Completed Octapharma 2013-07-31
NCT04371939 Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome https://ClinicalTrials.gov/show/NCT04371939 Recruiting Federal Research Institute of Pediatric Hematology, Oncology and Immunology 2022-12-31
NCT04070599 Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura. https://ClinicalTrials.gov/show/NCT04070599 Completed University Hospital, Bordeaux 2014-03-05
NCT02760251 Immunomodulation With Romiplostim in Young Adults With ITP https://ClinicalTrials.gov/show/NCT02760251 Completed University Hospital, Basel, Switzerland 2019-07-31
NCT04225156 A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP). https://ClinicalTrials.gov/show/NCT04225156 Recruiting argenx BVBA 2022-06-30
NCT04188379 A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP). https://ClinicalTrials.gov/show/NCT04188379 Recruiting argenx BVBA 2021-06-06
NCT02279173 Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT02279173 Completed Amgen 2018-08-30
NCT02052882 Study of Romiplostim for Chemotherapy Induced Thrombocytopenia https://ClinicalTrials.gov/show/NCT02052882 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-01-31
NCT04324060 A Randomized Trial of rhTPO Versus Placebo for Low/Intermediate-1 Risk MDS With Thrombocytopenia https://ClinicalTrials.gov/show/NCT04324060 Active, not recruiting Peking Union Medical College Hospital 2022-03-01
NCT03809481 An Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study to Evaluate the Safety and Efficacy of Danaparoid vs Argatroban https://ClinicalTrials.gov/show/NCT03809481 Active, not recruiting Aspen Global Incorporated 2021-01-31
NCT03688191 Study of Sirolimus in CTD-TP in China https://ClinicalTrials.gov/show/NCT03688191 Active, not recruiting Peking Union Medical College Hospital 2018-12-31
NCT03998982 Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP https://ClinicalTrials.gov/show/NCT03998982 Recruiting Shandong University 2020-04-01
NCT00774358 Interleukin-2 Treatment for Wiskott-Aldrich Syndrome https://ClinicalTrials.gov/show/NCT00774358 Completed Children’s Hospital of Philadelphia 2016-09-30
NCT00771810 Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer https://ClinicalTrials.gov/show/NCT00771810 Completed Tarix Pharmaceuticals 2011-12-31
NCT00759083 Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients https://ClinicalTrials.gov/show/NCT00759083 Completed The Medicines Company 2009-09-30
NCT00735930 Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma https://ClinicalTrials.gov/show/NCT00735930 Completed National Cancer Institute (NCI) 2013-03-31
NCT00730314 Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells https://ClinicalTrials.gov/show/NCT00730314 Completed Children’s Hospital Los Angeles 2015-08-31
NCT00614523 Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) https://ClinicalTrials.gov/show/NCT00614523 Completed Amgen 2011-03-31
NCT00608738 Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment https://ClinicalTrials.gov/show/NCT00608738 Completed Northwestern University 2005-01-31
NCT00515203 Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects https://ClinicalTrials.gov/show/NCT00515203 Completed Amgen 2009-03-31
NCT00508820 An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP https://ClinicalTrials.gov/show/NCT00508820 Completed Amgen 2011-01-01
NCT00493181 Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients https://ClinicalTrials.gov/show/NCT00493181 Completed M.D. Anderson Cancer Center 2011-01-31
NCT00489437 Heparin-Induced Thrombocytopenia Score Card Study https://ClinicalTrials.gov/show/NCT00489437 Completed McMaster University 2013-02-28
NCT00472290 Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS) https://ClinicalTrials.gov/show/NCT00472290 Completed Amgen 2011-07-18
NCT00418665 A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid https://ClinicalTrials.gov/show/NCT00418665 Completed Amgen 2009-03-31
NCT00415532 Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura https://ClinicalTrials.gov/show/NCT00415532 Completed Amgen 2008-11-07
NCT00413283 Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) https://ClinicalTrials.gov/show/NCT00413283 Completed Amgen 2008-12-31
NCT00412464 Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis https://ClinicalTrials.gov/show/NCT00412464 Completed FDA Office of Orphan Products Development 2009-06-30
NCT00367588 Low Bacterial Diet in Patients With Cytopenia https://ClinicalTrials.gov/show/NCT00367588 Completed Maastricht University Medical Center NA
NCT00358540 Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide https://ClinicalTrials.gov/show/NCT00358540 Completed GlaxoSmithKline 2010-10-22
NCT00344149 Rituximab as Second Line Treatment for ITP https://ClinicalTrials.gov/show/NCT00344149 Completed Ostfold Hospital Trust 2014-03-31
NCT00321711 Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents https://ClinicalTrials.gov/show/NCT00321711 Completed Amgen 2009-10-19
NCT00305708 Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission https://ClinicalTrials.gov/show/NCT00305708 Completed University of California, San Francisco 2004-07-31
NCT00305435 Safety Study of AMG 531 in Japanese Subjects With ITP https://ClinicalTrials.gov/show/NCT00305435 Completed Kyowa Kirin Co., Ltd. 2006-11-30
NCT00303472 Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS) https://ClinicalTrials.gov/show/NCT00303472 Completed Amgen 2008-05-31
NCT00301834 Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders https://ClinicalTrials.gov/show/NCT00301834 Completed University of California, San Francisco 2011-09-30
NCT00295971 Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease https://ClinicalTrials.gov/show/NCT00295971 Completed University of California, San Francisco 2011-12-31
NCT00283439 A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma https://ClinicalTrials.gov/show/NCT00283439 Completed Amgen 2008-05-31
NCT00263809 Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products https://ClinicalTrials.gov/show/NCT00263809 Completed Terumo BCTbio 2007-10-31
NCT00261924 Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days https://ClinicalTrials.gov/show/NCT00261924 Completed Cerus Corporation 2009-07-31
NCT00260689 Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia https://ClinicalTrials.gov/show/NCT00260689 Completed National Institutes of Health Clinical Center (CC) 2016-05-04
NCT00244010 Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias https://ClinicalTrials.gov/show/NCT00244010 Completed St. Jude Children’s Research Hospital 2008-11-30
NCT00220311 A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia https://ClinicalTrials.gov/show/NCT00220311 Completed Sanofi 2005-09-30
NCT00198588 Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia https://ClinicalTrials.gov/show/NCT00198588 Completed Ministry of Health, Labour and Welfare, Japan 2006-07-31
NCT00194987 A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia https://ClinicalTrials.gov/show/NCT00194987 Completed Weill Medical College of Cornell University 2015-06-30
NCT00151866 Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma https://ClinicalTrials.gov/show/NCT00151866 Completed Sanquin Research & Blood Bank Divisions NA
NCT00116688 Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) https://ClinicalTrials.gov/show/NCT00116688 Completed Amgen 2010-01-31
NCT00128713 Optimal Platelet Dose Strategy for Management of Thrombocytopenia https://ClinicalTrials.gov/show/NCT00128713 Completed HealthCore-NERI 2008-01-31
NCT00110799 SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C https://ClinicalTrials.gov/show/NCT00110799 Completed GlaxoSmithKline 2006-10-31
NCT00102726 SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT00102726 Completed GlaxoSmithKline 2007-02-28
NCT00102336 AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy https://ClinicalTrials.gov/show/NCT00102336 Completed Amgen 2006-12-01
NCT00102323 AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy https://ClinicalTrials.gov/show/NCT00102323 Completed Amgen 2006-09-01
NCT00004215 Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00004215 Completed Memorial Sloan Kettering Cancer Center 2000-08-31
NCT00002665 SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT00002665 Completed Southwest Oncology Group 2001-12-31
NCT00003619 Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT00003619 Completed National Cancer Institute (NCI) NA
NCT00073580 Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE) https://ClinicalTrials.gov/show/NCT00073580 Completed The Medicines Company 2005-09-30
NCT00031980 Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer https://ClinicalTrials.gov/show/NCT00031980 Completed Alliance for Clinical Trials in Oncology 2005-05-31
NCT00012376 Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer https://ClinicalTrials.gov/show/NCT00012376 Completed National Cancer Institute (NCI) 2010-01-31
NCT00001533 Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine https://ClinicalTrials.gov/show/NCT00001533 Completed National Institutes of Health Clinical Center (CC) NA
NCT00049725 Daclizumab to Treat Chronic Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT00049725 Completed National Institutes of Health Clinical Center (CC) NA
NCT00043940 Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning) https://ClinicalTrials.gov/show/NCT00043940 Completed The Medicines Company 2003-02-28
NCT00039910 Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia https://ClinicalTrials.gov/show/NCT00039910 Completed Pfizer NA
NCT00039858 Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin https://ClinicalTrials.gov/show/NCT00039858 Completed Encysive Pharmaceuticals NA
NCT00038311 Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia https://ClinicalTrials.gov/show/NCT00038311 Completed Pfizer NA
NCT00037791 Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia https://ClinicalTrials.gov/show/NCT00037791 Completed Pfizer NA
NCT00002258 A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia https://ClinicalTrials.gov/show/NCT00002258 Completed NIH AIDS Clinical Trials Information Service NA
NCT00004787 Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes https://ClinicalTrials.gov/show/NCT00004787 Completed Office of Rare Diseases (ORD) NA
NCT00001630 Treatment of Autoimmune Thrombocytopenia (AITP) https://ClinicalTrials.gov/show/NCT00001630 Completed National Institutes of Health Clinical Center (CC) NA
NCT00004378 Stem Cell Transplantation (SCT) for Genetic Diseases https://ClinicalTrials.gov/show/NCT00004378 Completed National Center for Research Resources (NCRR) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03820960 Risk Factors for Thrombosis in Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT03820960 Recruiting University Hospital, Toulouse 2020-02-29
NCT03251547 Recombinant Activated Factor VII in the Management of Massive Bleeding in Hospital Universiti Sains Malaysia https://ClinicalTrials.gov/show/NCT03251547 Completed Universiti Sains Malaysia 2017-10-15
NCT03110887 Monitoring Outcome in Neonatal Thrombocytopenia https://ClinicalTrials.gov/show/NCT03110887 Completed Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research 2016-10-21
NCT03026751 Improving Diagnosis in Idiopathic Cytopenia Using Gene Sequencing https://ClinicalTrials.gov/show/NCT03026751 Recruiting Royal Marsden NHS Foundation Trust 2021-04-30
NCT02891109 Regulatory B Cells and Chronic Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT02891109 Completed University Hospital, Brest 2015-09-30
NCT02862353 Thrombocytopenia Drug Immune Validation of New Biological Test Diagnostic https://ClinicalTrials.gov/show/NCT02862353 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2022-09-30
NCT02858323 Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion https://ClinicalTrials.gov/show/NCT02858323 Completed National Institutes of Health Clinical Center (CC) 2017-06-20
NCT02821572 Role of Fcgamma Receptors in Immune Thrombocytopenia (ITP) https://ClinicalTrials.gov/show/NCT02821572 Recruiting Centre Hospitalier Universitaire Dijon 2018-10-31
NCT02802982 Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates https://ClinicalTrials.gov/show/NCT02802982 Active, not recruiting Boston Children’s Hospital 2016-12-31
NCT02790567 Rapid Diagnosis of Heparin-Induced Thrombocytopenia in Surgical Critically Ill Patients https://ClinicalTrials.gov/show/NCT02790567 Completed Centre Hospitalier Universitaire de Besancon 2015-05-31
NCT02780414 Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers https://ClinicalTrials.gov/show/NCT02780414 Recruiting Progenity, Inc. 2020-05-31
NCT02717039 Pharmacogenomics of Heparin-Induced Thrombocytopenia https://ClinicalTrials.gov/show/NCT02717039 Recruiting University of Arizona 2022-12-31
NCT02526485 Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2 https://ClinicalTrials.gov/show/NCT02526485 Completed Vanderbilt University Medical Center 2018-09-05
NCT02371330 The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study https://ClinicalTrials.gov/show/NCT02371330 Completed Karolinska Institutet 2017-09-30
NCT02306044 Bleeding Prediction in Thrombocytopenia https://ClinicalTrials.gov/show/NCT02306044 Completed Odense University Hospital 2013-12-31
NCT02298075 Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT02298075 Recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2018-12-31
NCT02263157 Evaluate the Association Between Infection and Thrombocytopenia https://ClinicalTrials.gov/show/NCT02263157 Completed Jinling Hospital, China 2014-06-30
NCT02063763 TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients. https://ClinicalTrials.gov/show/NCT02063763 Recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2018-10-31
NCT01304238 Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II https://ClinicalTrials.gov/show/NCT01304238 Completed GlaxoSmithKline 2010-01-31
NCT02057185 Occupational Status and Hematological Disease https://ClinicalTrials.gov/show/NCT02057185 Active, not recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2019-03-31
NCT02042560 Study of Immune Thrombocytopenia Pathogenesis: https://ClinicalTrials.gov/show/NCT02042560 Completed Centre Hospitalier Universitaire Dijon 2015-03-12
NCT01974232 A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013 https://ClinicalTrials.gov/show/NCT01974232 Completed Weill Medical College of Cornell University 2013-06-30
NCT01971684 ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP https://ClinicalTrials.gov/show/NCT01971684 Completed Boston Children’s Hospital 2017-04-30
NCT01928017 Thromboelastography, Platelet Function and Platelet Recovery in Haemato-oncologic Patients With Thrombocytopenia https://ClinicalTrials.gov/show/NCT01928017 Completed University of Bergen 2014-06-30
NCT01727999 Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics https://ClinicalTrials.gov/show/NCT01727999 Completed Stanford University 2017-02-28
NCT01727232 Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult’s Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT01727232 Completed Henri Mondor University Hospital 2012-06-30
NCT01668615 Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT01668615 Completed First Affiliated Hospital of Suzhou Medical College 2012-08-31
NCT01666795 Autoantibody Specificity and Response to IVIG in ITP https://ClinicalTrials.gov/show/NCT01666795 Completed Shandong University 2013-01-31
NCT01654848 Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients https://ClinicalTrials.gov/show/NCT01654848 Completed CHIR-Net 2011-08-31
NCT01618734 Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety. https://ClinicalTrials.gov/show/NCT01618734 Completed Henri Mondor University Hospital 2012-06-30
NCT01549184 Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT01549184 Completed Henri Mondor University Hospital 2011-12-31
NCT01356576 Effect of Hemodialysis Membranes on Platelet Count https://ClinicalTrials.gov/show/NCT01356576 Completed Northwell Health 2011-09-30
NCT01338363 Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists https://ClinicalTrials.gov/show/NCT01338363 Completed AstraZeneca 2015-08-31
NCT03605511 TTP and aHUS in Complicated Pregnancies https://ClinicalTrials.gov/show/NCT03605511 Recruiting University College, London 2020-03-14
NCT04350164 Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome. https://ClinicalTrials.gov/show/NCT04350164 Active, not recruiting Federal Research Institute of Pediatric Hematology, Oncology and Immunology 2019-12-27
NCT04348799 Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary Dysplasia https://ClinicalTrials.gov/show/NCT04348799 Completed Guangdong Women and Children Hospital 2020-01-01
NCT04268940 Thrombo-Elastography Guided Management of ECMO https://ClinicalTrials.gov/show/NCT04268940 Recruiting University Health Network, Toronto 2021-08-01
NCT04159064 Impact of Cardiac Surgery With a Minimal Invasive Extracorporeal Circuit οn Coagulation: Data From Point of Care Devices https://ClinicalTrials.gov/show/NCT04159064 Completed AHEPA University Hospital 2019-04-30
NCT04102423 CHIP/CCUS Natural History Protocol https://ClinicalTrials.gov/show/NCT04102423 Recruiting National Institutes of Health Clinical Center (CC) 2033-09-15
NCT04071496 Diagnostic of Chronic Thrombocytopenia https://ClinicalTrials.gov/show/NCT04071496 Completed University Hospital, Bordeaux 2012-03-12
NCT04067375 Towards Routine HPA-screening In Pregnancy to Prevent FNAIT https://ClinicalTrials.gov/show/NCT04067375 Recruiting Leiden University Medical Center 2020-04-01
NCT03998059 Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients https://ClinicalTrials.gov/show/NCT03998059 Recruiting Institute of Hematology & Blood Diseases Hospital 2022-01-23
NCT03979625 Prognosis Related to Induced Thrombopenia With Heparin Under Venoarterial ECMO in Reanimation https://ClinicalTrials.gov/show/NCT03979625 Completed Central Hospital, Nancy, France 2018-04-30
NCT03848923 Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation https://ClinicalTrials.gov/show/NCT03848923 Recruiting Boston Children’s Hospital 2022-03-01
NCT03835598 Post-Operative Thrombocytopenia After Bio-prosthesis Implantation https://ClinicalTrials.gov/show/NCT03835598 Recruiting Maastricht University Medical Center 2020-02-29
NCT03810352 Association of Platelet Parameters With Bleeding Severity in Children With ITP https://ClinicalTrials.gov/show/NCT03810352 Recruiting Boston Children’s Hospital 2021-02-01
NCT03767803 Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women https://ClinicalTrials.gov/show/NCT03767803 Active, not recruiting Progenity, Inc. 2020-12-31
NCT03716310 Platelet Reactivity in Septic Shock https://ClinicalTrials.gov/show/NCT03716310 Completed Università degli Studi di Ferrara 2018-05-30
NCT03636698 Effect of Chorioamnionitis on Platelet Activation and Placental Vessel Among Preterm Infants by Wnt-Flt1 Signal Pathway https://ClinicalTrials.gov/show/NCT03636698 Completed Guangdong Women and Children Hospital 2016-12-31
NCT03617965 Mortality Due to Septic Shock Associated With Thrombocytopenia https://ClinicalTrials.gov/show/NCT03617965 Active, not recruiting Universidad de Guanajuato 2019-11-15
NCT03515447 Romiplostim in Thoracic Transplantation https://ClinicalTrials.gov/show/NCT03515447 Completed Nantes University Hospital 2015-10-31
NCT03505086 Bleeding In Thrombocytopenia Explained https://ClinicalTrials.gov/show/NCT03505086 Recruiting Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research 2022-10-01
NCT03469661 Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS) https://ClinicalTrials.gov/show/NCT03469661 Recruiting Fundacion CRIS de Investigación para Vencer el Cáncer 2020-04-30
NCT03429660 French Adult Primary Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT03429660 Recruiting University Hospital, Toulouse 2023-05-31
NCT01236014 Indirect Comparison Between Eltrombopag & Romiplostim https://ClinicalTrials.gov/show/NCT01236014 Completed GlaxoSmithKline 2009-10-31
NCT01235988 Meta-analysis - Eltrombopag https://ClinicalTrials.gov/show/NCT01235988 Completed GlaxoSmithKline 2009-10-31
NCT01178333 Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study https://ClinicalTrials.gov/show/NCT01178333 Completed HealthCore-NERI 2010-12-31
NCT01013181 Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults https://ClinicalTrials.gov/show/NCT01013181 Completed Henri Mondor University Hospital 2008-07-31
NCT00925236 Phenotypic and Genotypic Identification and Characterization of MYH9-related Constitutional Thrombocytopenia https://ClinicalTrials.gov/show/NCT00925236 Completed Assistance Publique - Hôpitaux de Paris 2015-07-31
NCT01672151 Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia https://ClinicalTrials.gov/show/NCT01672151 Completed First Affiliated Hospital of Suzhou Medical College 2012-08-31
NCT04155775 Effects of a Platelet Transfusion Best Practices Alert https://ClinicalTrials.gov/show/NCT04155775 Enrolling by invitation Stanford University 2019-12-31
NCT04005638 Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia https://ClinicalTrials.gov/show/NCT04005638 Recruiting University Hospital, Bordeaux 2022-02-28
NCT00787241 Platelet Count Trends in Pre-eclamptic Parturients https://ClinicalTrials.gov/show/NCT00787241 Completed Northwestern University 2003-05-31
NCT00759980 Transfusing Neonates Based on Platelet Mass https://ClinicalTrials.gov/show/NCT00759980 Completed Christiana Care Health Services 2011-03-31
NCT00748878 Platelet Function During ECMO (Extra Corporeal Membrane Oxygenation) https://ClinicalTrials.gov/show/NCT00748878 Completed University of Utah 2012-06-30
NCT00748839 Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical https://ClinicalTrials.gov/show/NCT00748839 Completed Centre Hospitalier Universitaire de Saint Etienne 2012-11-30
NCT00682799 Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC) https://ClinicalTrials.gov/show/NCT00682799 Completed University Hospital Freiburg 2013-03-31
NCT00576888 Registry for Vascular Anomalies Associated With Coagulopathy https://ClinicalTrials.gov/show/NCT00576888 Completed Medical College of Wisconsin 2018-12-31
NCT00549484 Thrombopoietin Levels and Platelet Transfusion in Neonates https://ClinicalTrials.gov/show/NCT00549484 Completed Christiana Care Health Services 2004-09-30
NCT00456326 Heparin-Induced Thrombocytopenia Registry https://ClinicalTrials.gov/show/NCT00456326 Completed Brigham and Women’s Hospital NA
NCT00456001 Heparin Induced Thrombocytopenia: Pharmacoeconomics https://ClinicalTrials.gov/show/NCT00456001 Completed Brigham and Women’s Hospital 2008-09-30
NCT00454857 Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) https://ClinicalTrials.gov/show/NCT00454857 Completed Amgen 2008-06-30
NCT00336687 Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation. https://ClinicalTrials.gov/show/NCT00336687 Completed University Hospital, Clermont-Ferrand NA
NCT00333333 Mechanism of Thrombocytopenia in Infants https://ClinicalTrials.gov/show/NCT00333333 Completed Christiana Care Health Services 2008-03-31
NCT00283322 Heparin Antibodies in Intensive Care Unit Patients (HAICU) https://ClinicalTrials.gov/show/NCT00283322 Completed The University of Texas Health Science Center, Houston NA
NCT00118664 Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children https://ClinicalTrials.gov/show/NCT00118664 Completed Children’s Healthcare of Atlanta 2012-02-29
NCT00015639 Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus https://ClinicalTrials.gov/show/NCT00015639 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03288441 Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia https://ClinicalTrials.gov/show/NCT03288441 Recruiting Maastricht University Medical Center 2019-07-31
NCT02877706 Autoimmune Cytopenias : Midi-Pyrenees Registry https://ClinicalTrials.gov/show/NCT02877706 Recruiting University Hospital, Toulouse 2023-06-30
NCT02720679 Investigation of the Genetics of Hematologic Diseases https://ClinicalTrials.gov/show/NCT02720679 Recruiting St. Jude Children’s Research Hospital 2026-08-31
NCT02068755 Blood Products in Cardiac Surgery https://ClinicalTrials.gov/show/NCT02068755 Completed University of Turku 2012-12-31
NCT01970189 The International ITP Registry https://ClinicalTrials.gov/show/NCT01970189 Recruiting South Eastern Sydney Local Health District 2016-12-31
NCT01933035 Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias. https://ClinicalTrials.gov/show/NCT01933035 Completed Beth Israel Medical Center 2015-10-31
NCT03576742 Severe Immune Cytopenia Registry Www.Sic-reg.Org https://ClinicalTrials.gov/show/NCT03576742 Recruiting Medical University of Graz 2022-03-08